Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - WINDTREE THERAPEUTICS INC /DE/ | wint20201231_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - WINDTREE THERAPEUTICS INC /DE/ | ex_216213.htm |
| EX-31.2 - EXHIBIT 31.2 - WINDTREE THERAPEUTICS INC /DE/ | ex_216212.htm |
| EX-31.1 - EXHIBIT 31.1 - WINDTREE THERAPEUTICS INC /DE/ | ex_216211.htm |
| EX-4.16 - EXHIBIT 4.16 - WINDTREE THERAPEUTICS INC /DE/ | ex_216206.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1. |
Registration Statement (Form S-1 No. 333-217161, Form S-1 No. 333-231128, Form S-1 No. 333-235977, and Form S-1 333-236085) of Windtree Therapeutics, Inc. and in related Prospectuses, |
|
2. |
Registration Statement (Form S-3 No. 333-248874) of Windtree Therapeutics, Inc. and in related Prospectuses, |
|
3. |
Registration Statement (Form S-8 No. 333-180497, Form S-8 No. 333-184277, Form S-8 No. 333-189966, Form S-8 No. 333-197139, Form S-8 No. 333-209141, Form S-8 No. 333-224338, and Form S-8 No. 333-230907) pertaining to the Windtree Therapeutics, Inc. 2011 Long-Term Incentive Plan, |
|
4. |
Registration Statement (Form S-8 No. 333-148028) pertaining to the Windtree Therapeutics, Inc. 2007 Long-Term Incentive Plan, |
|
5. |
Registration Statement (Form S-8 No. 333-33900, Form S-8 No. 333-55900, Form S-8 No. 333-67422, Form S-8 No. 333-100824, Form S-8 No. 333-109274, Form S-8 No. 333-116268, Form S-8 No. 333-127790, Form S-8 No. 333-138476, Form S-8 No. 333-208879, Form S-3 No. 333-209141 and Form S-8 No. 210464) pertaining to the Amended and Restated 1998 Stock Incentive Plan of Windtree Therapeutics, Inc., |
|
6. |
Registration Statement (Form S-8 No. 333-59945) pertaining to the Amended and Restated 1998 Stock Incentive Plan of Windtree Therapeutics, Inc., the 1996 Stock Option/Stock Issuance Plan of Windtree Therapeutics, Inc., and the 1996 Stock Option/ Stock Issuance Plan of Acute Therapeutics, Inc., |
|
7. |
Registration Statement (Form S-8 No. 333-110412, Form S-8 No. 333-137643, Form S-8 No. 333-156443, Form S-8 No. 333-164470, Form S-8 No. 333-165809, Form S-8 No. 333-169662, Form S-8 No. 333-173259, Form S-8 No.333-180497, Form S-8 No. 333-187486, Form S-8 No. 333-191502, Form S-8 No. 333-197139, Form S-8 No. 333-201478, Form S-8 No. 333-208879, and S-8 No. 333-209141) pertaining to the 401(k) Plan of Windtree Therapeutics, Inc., |
|
8. |
Registration Statement (Form S-8 No. 333-253065) pertaining to the Windtree Therapeutics, Inc. 2020 Equity Incentive Plan, and |
|
9. |
Registration Statement (Form S-8 No. 333-253067) pertaining to certain Non-Qualified Stock Option Inducement Awards; |
of our report dated March 29, 2021, with respect to the consolidated financial statements of Windtree Therapeutics, Inc. and subsidiaries included in this Annual Report (Form 10-K) of Windtree Therapeutics, Inc. and subsidiaries for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania